Olanzapine for the Treatment of Bipolar Disorder

View This PDF

NB: This article is only available as a PDF.

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: In a recent issue of the Companion, Masand and colleagues1 report a retrospective analysis of 36 outpatients with bipolar or schizoaffective disorder in which risperidone and olanzapine were comparable in efficacy and safety, but treatment costs were lower for risperidone-treated patients. Although the acquisition costs of risperidone are lower than those of olanzapine, when other factors are taken into account, the costs of the 2 agents do not differ appreciably. As the authors point out in their article, atypical antipsychotics are becoming commonly prescribed agents in primary care settings.​

Primary Care Companion J Clin Psychiatry 2002;4(3):113-114 [letter]

https://doi.org/10.4088/PCC.v04n0307